These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 26295340

  • 1. Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani.
    Das S, Shah P, Tandon R, Yadav NK, Sahasrabuddhe AA, Sundar S, Siddiqi MI, Dube A.
    PLoS Negl Trop Dis; 2015 Aug; 9(8):e0003992. PubMed ID: 26295340
    [Abstract] [Full Text] [Related]

  • 2. Over-expression of 60s ribosomal L23a is associated with cellular proliferation in SAG resistant clinical isolates of Leishmania donovani.
    Das S, Shah P, Baharia RK, Tandon R, Khare P, Sundar S, Sahasrabuddhe AA, Siddiqi MI, Dube A.
    PLoS Negl Trop Dis; 2013 Aug; 7(12):e2527. PubMed ID: 24340105
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the proliferating cell nuclear antigen of Leishmania donovani clinical isolates and its association with antimony resistance.
    Tandon R, Chandra S, Baharia RK, Das S, Misra P, Kumar A, Siddiqi MI, Sundar S, Dube A.
    Antimicrob Agents Chemother; 2014 Jun; 58(6):2997-3007. PubMed ID: 24614385
    [Abstract] [Full Text] [Related]

  • 4. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R.
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [Abstract] [Full Text] [Related]

  • 5. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
    Bhandari V, Kumar D, Verma S, Srividya G, Negi NS, Singh R, Salotra P.
    Biochem Biophys Res Commun; 2013 Nov 01; 440(4):646-51. PubMed ID: 24103752
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani.
    Mukherjee A, Padmanabhan PK, Singh S, Roy G, Girard I, Chatterjee M, Ouellette M, Madhubala R.
    J Antimicrob Chemother; 2007 Feb 01; 59(2):204-11. PubMed ID: 17213267
    [Abstract] [Full Text] [Related]

  • 8. Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani.
    Maharjan M, Singh S, Chatterjee M, Madhubala R.
    Am J Trop Med Hyg; 2008 Jul 01; 79(1):69-75. PubMed ID: 18606765
    [Abstract] [Full Text] [Related]

  • 9. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.
    Subba Raju BV, Gurumurthy S, Kuhls K, Bhandari V, Schnonian G, Salotra P.
    Parasitol Res; 2012 Oct 01; 111(4):1559-68. PubMed ID: 22752721
    [Abstract] [Full Text] [Related]

  • 10. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
    Mukhopadhyay R, Mukherjee S, Mukherjee B, Naskar K, Mondal D, Decuypere S, Ostyn B, Prajapati VK, Sundar S, Dujardin JC, Roy S.
    Int J Parasitol; 2011 Nov 01; 41(13-14):1311-21. PubMed ID: 21920365
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites.
    Singh R, Kumar D, Duncan RC, Nakhasi HL, Salotra P.
    Int J Antimicrob Agents; 2010 Jul 01; 36(1):50-7. PubMed ID: 20427152
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance.
    Zheng Z, Chen J, Ma G, Satoskar AR, Li J.
    Parasit Vectors; 2020 Oct 12; 13(1):510. PubMed ID: 33046138
    [Abstract] [Full Text] [Related]

  • 15. Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani.
    Kumar D, Singh R, Bhandari V, Kulshrestha A, Negi NS, Salotra P.
    Parasitol Res; 2012 Jul 12; 111(1):223-30. PubMed ID: 22302478
    [Abstract] [Full Text] [Related]

  • 16. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
    Singh N, Chatterjee M, Sundar S.
    Parasit Vectors; 2014 Dec 17; 7():596. PubMed ID: 25515494
    [Abstract] [Full Text] [Related]

  • 17. Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.
    Haldar AK, Yadav V, Singhal E, Bisht KK, Singh A, Bhaumik S, Basu R, Sen P, Roy S.
    PLoS Pathog; 2010 May 20; 6(5):e1000907. PubMed ID: 20502630
    [Abstract] [Full Text] [Related]

  • 18. Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar.
    Khanra S, Sarraf NR, Das S, Das AK, Roy S, Manna M.
    Acta Trop; 2016 Dec 20; 164():177-184. PubMed ID: 27629023
    [Abstract] [Full Text] [Related]

  • 19. Integrating genomics and proteomics permits identification of immunodominant antigens associated with drug resistance in human visceral leishmaniasis in India.
    Singh N, Sundar S.
    Exp Parasitol; 2017 May 20; 176():30-45. PubMed ID: 28263760
    [Abstract] [Full Text] [Related]

  • 20. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
    Samant M, Sahasrabuddhe AA, Singh N, Gupta SK, Sundar S, Dube A.
    Parasitology; 2007 Aug 20; 134(Pt 9):1175-84. PubMed ID: 17362540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.